PAPILLARY THYROID CARCINOMA IN CHILDREN AND ADOLESCENTS, RESULTS OF TREATMENT OF 215 PATIENTS: FACTORS PREDICTING DISTANT METASTASES AND RECURRENCE OF THE DISEASE
##article.numberofdownloads## 51
##article.numberofviews## 484
PDF (Русский)

Keywords

PAPILLARY THYROID CANCER
CHILDREN
ADOLESCENT
PROGNOSTIC FACTORS
RECURRENCE
DISTANT METASTASES

How to Cite

Ilin, A., Semin, D., Isaev, P., Severskaya, N., Sevryukov, F., Polkin, V., Vasilkov, S., Kaprin, A., & Ivanov, S. (2018). PAPILLARY THYROID CARCINOMA IN CHILDREN AND ADOLESCENTS, RESULTS OF TREATMENT OF 215 PATIENTS: FACTORS PREDICTING DISTANT METASTASES AND RECURRENCE OF THE DISEASE. Voprosy Onkologii, 64(6), 752–757. https://doi.org/10.37469/0507-3758-2018-64-6-752-757

Abstract

We evaluated the results of treatment of 215 pediatric patients with papillary thyroid carcinoma (PTC). Median age at diagnosis was 14 (5 - 18 y.o). Thyroidectomy performed in 105, subtotalthyroidectomy in 8, lobectomy - in 102, additional lymph node dissection - in 169, radioiodine ablation/ therapy - in 102 patients. Follicular variant PTC was found in 41 (19%), solid - in 37 (17%), diffuse sclerosing - in 3 (1%), the remaining had a classical PTC with mainly papillary (90; 42%) or follicular (44; 21%) pattern. 21% had multifocal PTC, 4,6% - extrathyroidal extension, 62% - regional lymph node metastases, 12% - lung metastases. The follow up was 95 months (6 - 301 mo). All patients are alive. Recurrence of PTC occurred in 37 (17%): 7 - thyroid remnant, 26 - cervical lymph nodes, 4 - distant lung metastases. Prognostic factors for distant metastases were young age at diagnosis <12 years old (OR 3.4, р <0.022), tumor size more then 3 cm (OR 3.2, р <0.027) and lateral cervical lymph node metastases (OR 21.39, р <0.0001). Risk of recurrence was higher in multifocal PTC (OR 2.4, р <0.009), regional lymph node metastases (OR 7.4, р <0,008) and distant metastases (OR 3.2, р <0,01). The highest risk of relapse had the patients with solid variant of PTC. Radical surgery diminished the risk of relapse (OR 0.3, р <0.002). There was no evidence of impact of radioiodine therapy on risk of recurrence (р=0.66).

https://doi.org/10.37469/0507-3758-2018-64-6-752-757
##article.numberofdownloads## 51
##article.numberofviews## 484
PDF (Русский)

References

Каприн А.Д., Галкин В.Н., Жаворонков Л.П. и др. Синтез фундаментальных и прикладных исследований - основа обеспечения высокого уровня научных результатов и внедрения их в медицинскую практику // Радиация и риск. - 2017. - Т. 26. - № 2. - С. 26-40.

Шишков Р.В., Поляков В.Г., Павловская А.И. и др. Новая стратегия диагностики и лечения рака щитовидной железы у детей и подростков // Врач. - 2006. - № 13. - С. 36-40.

Alessandri A.J., Goddard K.J., Blair G.K. et al. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma // Med. Pediatr. Oncol. - 2000. - Vol. 35. - P. 41-46. - X(200007)35:13.0.CO;2-7. DOI: 10.1002/1096911

Bal C.S., Padhy A.K., Kumar A. Clinical features differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone // Nucl. Med. Commun. - 2001. - Vol. 22. - P 881-887. - DOI: 10.1097/00006231200108000-00006

Balachandar S., La Quaglia M., Tuttle R.M. et al. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes // Thyroid. - 2016. - Vol. 26. - № 2. - P 219-226. - DOI: 10.1089/thy.2015.0287

Collini P., Mattavelli F., Pellegrinelli A. et al. Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinopathologic study of 42 sporadic cases treated at a single institution during a 30-year period // Am J. Surg. Pathol. - 2006. - Vol. 30. - № 11. - P. 1420-1426. - DOI: 10.1097/01.pas.0000213264.07597.9a

Demidchik Y.E., Demidchik E.P, Reiners C. et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus // Ann Surg. - 2006. - Vol. 243. - № 4. - Р 525532. - DOI: 10.1097/01.sla.0000205977.74806.0b

Grigsby P.W., Gal-or A., Michalski J.M., Doherty G.M. Childhood and adolescent thyroid carcinoma // Cancer. - 2002. - Vol. 95. - P. 724-729. - DOI: 10.1002/cncr.10725

Greenlee R.T., Hill-Harmon M.B., Murray T., Thun М. Cancer statistics, 2001 // Cancer Journal for Clinicans. - 2001. - Vol. 51. - № 1. - P 15-36. - DOI: 10.3322/canjclin.51.1.15

Hay I.D., Gonzalez-Losada T, Reinalda M.S. et al. Longterm outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008 // World J. Surg. - 2010. - Vol. 34. - № 6. - P. 1192-1202. - DOI: 10.1007/s00268-009-0364-0

Jarzab B., Handkiewicz-Junak D., Wloch J. et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children // Eur. J. Nucl. Med. - 2000. - Vol. 27. - P 833-841. - DOI: 10.1007/s002590000271

Kuo S.F., Chao T.C., Hsuen С. et al. Prognosis and risk stratification in young papillary thyroid carcinoma patients // Endocrine Journal. - 2008. - Vol. 55. - P. 269275. - DOI: 10.1507/endocrj.K07-127

Landau D., Vini L., A'Hern R., Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience // Eur. J. Cancer. - 2000. - Vol. 36. - P. 214-220. - DOI: 10.1016/S0959-8049(99)00281-6

Lazar L., Lebenthal Y., Segal K. et al. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors // J. Clin. Endocrinol. Metab. - 2016. - Vol. 101. - № 5. - P 1970-1979. - DOI: 10.1210/jc.2015-3960

Markovina S.1., Grigsby P.W., Schwarz J.K. et al. Treatment approach, surveillance, and outcome of well-differentiated Thyroid cancer in childhood and adolescence // Thyroid. - 2014. - Vol. 24. - № 7. - P 11211126. - DOI: 10.1089/thy.2013.0297

Mihailovic J., Nikoletic K., Srbovan D. Recurrent diseas e in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes // J. Nucl. Med. - 2014. - Vol. 55. - № 5. - P. 710-717. - DOI: 10.2967/jnumed.113.130450

Sung T.Y., Jeon M.J., Lee Y.H. et al. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer // J. Clin. Endocrinol. Metab. - 2017. - Vol. 102. - № 3. - P 793-800. - DOI: 10.1210/jc.2016-2666

Vaisman F., Bulzico D.A., Pessoa C.H. et al. Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer // Clinics (Sao Paulo). - 2011. - Vol. 66. - № 2. - P. 281-286. - DOI: 10.1590/S1807-59322011000200017

Wada N., Sugino K., Mimura T. et al. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival // BMC Cancer. - 2009. - Vol. 9. - № 306. -P. 1-8. - DOI: 10.1186/1471-2407-9-306

Wang C., Chen X., Wei X. et al. Recurrence factors an d prevention of complications of pediatric differentiated thyroid cancer // Asian J. Surg. - 2017. - Vol. 40. - № 1. - P. 55-60. - DOI: 10.1016/j.asjsur.2016.09.001

Welch Dinauer C.A., Tuttle R.M., Robie D.K. et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults // Clin. Endocrinol. (Oxf). - 1998. - Vol. 49. - P. 619-628. - DOI: 10.1046/j.1365-2265.1998.00584.x

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2018